We are live on ! Find out more
TIL icon

Instil Bio

30 hedge funds and large institutions have $30M invested in Instil Bio in 2023 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 9 increasing their positions, 16 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

57.55% more ownership

Funds ownership: 3.08%60.64% (+58%)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

13% less capital invested

Capital invested by funds: $34.3M → $30M (-$4.3M)

44% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 16

48% less funds holding

Funds holding: 5830 (-28)

93% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 30

Holders
30
Holders Change
-28
Holders Change %
-48.28%
% of All Funds
0.44%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
2
Increased
9
Reduced
16
Closed
30
Calls
Puts
Net Calls
Net Calls Change

TIL Hedge Fund Activity: Q4 2023 in Review

30 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Instil Bio (TIL) for Q4 2023, worth a combined $30M — down 13% from $34.3M a quarter earlier.

Sellers outnumbered buyers: 30 funds closed out of TIL and 2 opened new positions — a net loss of 28 holders — while 16 trimmed existing stakes and 9 added.

The largest buyer was Nantahala Capital Management, adding an estimated $559K. The largest seller was Baker Bros. Advisors, exiting entirely with an estimated $2.01M sold.

  • 30 institutional investors held Instil Bio (TIL) as of Q4 2023, down from 58 in Q3 2023.
  • Funds reported $30M of Instil Bio stock for Q4 2023, down 13% quarter-over-quarter.
  • 2 funds opened new Instil Bio positions in Q4 2023 and 30 closed out, a net change of -28 holders.
  • The largest Instil Bio buyer in Q4 2023 was Nantahala Capital Management, an estimated $559K added.
  • The largest Instil Bio seller in Q4 2023 was Baker Bros. Advisors, an estimated $2.01M sold.

Based on aggregated 13F filings for Q4 2023.